Iridian Asset Management LLC Precigen, Inc. Call Options Transaction History

Iridian Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 02, 2022	SELL	$1.91 - $3.98 $57,300 - $119,400	-30,000 Reduced 27.27%	80,000 $169,000
Q4 2021 Feb 10, 2022	BUY	$3.53 - $5.5 $211,800 - $330,000	60,000 Added 120.0%	110,000 $408,000
Q2 2021 Aug 11, 2021	BUY	$6.24 - $8.22 $124,800 - $164,400	20,000 Added 66.67%	50,000 $326,000
Q1 2021 May 11, 2021	SELL	$6.74 - $10.95 $6,740 - $10,950	-1,000 Reduced 3.23%	30,000 $207,000
Q4 2020 Feb 08, 2021	SELL	$3.75 - $10.56 $270,750 - $762,432	-72,200 Reduced 69.96%	31,000 $316,000
Q3 2020 Nov 02, 2020	BUY	$3.5 - $6.2 $3,500 - $6,200	1,000 Added 0.98%	103,200 $361,000
Q1 2020 May 11, 2020	BUY	$1.46 - $7.19 $149,212 - $734,818	102,200 New	102,200 $347,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Iridian Asset Management LLC with notifications on news.